MedTrace Logo

Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy

NCT02869308 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-08-17

No results posted yet for this study

Summary

The purpose is to determine whether measurements of left ventricular ejection fraction (LVEF) obtained with angiographies recorded by conventional Anger camera or D-SPECT camera are equivalent.

Secondary purposes are:

* To evaluate the influence of cardiac activity recorded by D-SPECT camera on equivalences defined in primary purpose
* To evaluate the influence of the indication for the examination with a distinct analysis of a group having the examination for a known or suspected cardiomyopathy (LVEF often abnormally low) and a group having the examination for a chemotherapy supervision with heart initially considered healthy (LVEF often normal).

Conditions

  • Angioscintigraphy
  • Tomoscintigraphy

Interventions

DRUG

stannous pyrophosphate

Injection of 1ml Angiocis

DRUG

Technetium-99m

Injection of 900 MBq Technetium-99m, 30 min after Angiocis injection

DEVICE

E-CAM Camera

Acquisition of images of angioscintigraphy with E-CAM camera, after injection of Angiocis and Technetium-99m

DEVICE

CZT Semiconductor Camera (D-SPECT)

Acquisition of images of angioscintigraphy with D-SPECT camera

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Gilles KARCHER, Pr · CHU de NANCY - Service de Médecine Nucléaire - France

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-01-31
Completion
2018-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869308 on ClinicalTrials.gov